Trends in Survival After Surgery for Breast Cancer Metastatic to the Brain and Spinal Column in Medicare Patients: A Population-Based Analysis

被引:16
作者
Cahill, Kevin S. [1 ]
Chi, John H. [1 ]
Day, Art L. [1 ]
Claus, Elizabeth B. [1 ,2 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Dept Neurosurg, Sch Med, Boston, MA 02115 USA
[2] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA
关键词
Breast cancer; Craniotomy; Laminectomy; Postoperative survival; Spinal fusion; NERVOUS-SYSTEM METASTASES; SURGICAL-TREATMENT; PROGNOSTIC-FACTORS; RANDOMIZED-TRIAL; CNS METASTASES; CARCINOMA; TUMORS; TRASTUZUMAB; PREDICTION; RESECTION;
D O I
10.1227/NEU.0b013e31820773b2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND: Central nervous system (CNS) metastases are a common occurrence in patients with breast cancer and are identified in up to 30% of patients at autopsy. OBJECTIVE: To determine population-based estimates of survival times after surgical intervention for Medicare patients with metastatic breast cancer to the brain and spinal column. METHODS: Female breast cancer patients with metastases to the brain and spinal column and undergoing neurosurgical treatment were identified through the Surveillance, Epidemiology, and End Results-Medicare database. Estimates of survival were calculated with Kaplan-Meier estimation and a Cox proportional hazards model. RESULTS: There were 643 patients who underwent neurosurgical treatment of metastatic disease from 1986 to 2005. Of these patients, 264 underwent cranial surgery and 379 underwent spinal surgery. There were 40 deaths during the postoperative hospital admission for an inpatient postoperative death rate of 6.2%. Inpatient death has declined by approximately 50% for surgeries performed in the most recent decade; however, the 30-day mortality rate of 9.0% has remained constant. The median postoperative survival after cranial surgery was 7.8 months (95% confidence interval, 6.2-9.2), after laminectomy was 9.4 months (95% confidence interval, 6.3-15.7), and after spinal fusion was 15.7 months (95% confidence interval, 11.9-18.5). Survival after spinal fusion has increased by approximately 50% in the recent decade. Patients with increased survival after cranial surgery were younger, had fewer comorbidities, and had longer periods from breast cancer diagnosis to surgery. Patients with increased survival after spinal neurosurgery had lower-grade lesions and longer time periods from breast cancer diagnosis to surgical treatment. CONCLUSION: After surgically treated metastases, one-third of cranial patients and one-half of spinal patients are alive at 1 year. The overall postoperative survival has increased over time only for spinal fusion procedures.
引用
收藏
页码:705 / 713
页数:9
相关论文
共 50 条
  • [41] A validated survival score for breast cancer patients with metastatic spinal cord compression
    Rades, D.
    Douglas, S.
    Schild, S. E.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 (01) : 41 - 46
  • [42] Incidence and survival in patients with sinonasal cancer: A historical analysis of population-based data
    Turner, Justin H.
    Reh, Douglas D.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2012, 34 (06): : 877 - 885
  • [43] Population-based study of breast cancer survival in Cote d'Or (France): prognostic factors and relative survival
    Dabakuyo, T. S.
    Bonnetain, F.
    Roignot, P.
    Poillot, M. -L.
    Chaplain, G.
    Altwegg, T.
    Hedelin, G.
    Arveux, P.
    ANNALS OF ONCOLOGY, 2008, 19 (02) : 276 - 283
  • [44] Survival Outcomes of Metaplastic Breast Cancer Patients: Results from a US Population-based Analysis
    Nelson, Rebecca A.
    Guye, Mary L.
    Luu, Thehang
    Lai, Lily L.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (01) : 24 - 31
  • [45] Exercise boost after surgery improves survival in model of metastatic breast cancer
    Stagaard, Rikke
    Jensen, Adina
    Schauer, Tim
    Bay, Marie Lund
    Tavanez, Ana Rita
    Wielsoe, Sabrina
    Peletier, Merel
    Strobech, Jan Erik
    Oria, Victor Oginga
    Zornhagen, Kamilla Westarp
    Albrechtsen, Reidar
    Christensen, Jesper Frank
    Erler, Janine Terra
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [46] Survival of Patients With Neuroendocrine Carcinoma of the Colon and Rectum: A Population-Based Analysis
    Shafqat, Hammad
    Ali, Shihab
    Salhab, Mohammed
    Olszewski, Adam J.
    DISEASES OF THE COLON & RECTUM, 2015, 58 (03) : 294 - 303
  • [47] Survival after bilateral breast cancer: results from a population-based study
    Verkooijen, Helena M.
    Chatelain, Vanessa
    Fioretta, Gerald
    Vlastos, Georges
    Rapiti, Elisabetta
    Sappino, Andre-Pascal
    Bouchardy, Christine
    Chappuis, Pierre O.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 105 (03) : 347 - 357
  • [48] Survival analysis of patients with metastatic osteosarcoma: a Surveillance, Epidemiology, and End Results population-based study
    Song, Kehan
    Song, Jian
    Lin, Kaiyuan
    Chen, Feiyan
    Ma, Xiaosheng
    Jiang, Jianyuan
    Li, Feng
    INTERNATIONAL ORTHOPAEDICS, 2019, 43 (08) : 1983 - 1991
  • [49] Trends in Overall Survival and Treatment Patterns in Two Large Population-Based Cohorts of Patients with Breast and Colorectal Cancer
    van Abbema, Doris
    Vissers, Pauline
    de Vos-Geelen, Judith
    Lemmens, Valery
    Janssen-Heijnen, Maryska
    Tjan-Heijnen, Vivianne
    CANCERS, 2019, 11 (09)
  • [50] Disparities in survival after female breast cancer diagnosis: a population-based study
    Tannenbaum, Stacey L.
    Koru-Sengul, Tulay
    Miao, Feng
    Byrne, Margaret M.
    CANCER CAUSES & CONTROL, 2013, 24 (09) : 1705 - 1715